Crossmark

The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

Published Online: 2021-04-12

Published Print: 2021-12

Authors

Rahimi, Arash

Samimagham, Hamid Reza

Azad, Mehdi Hassani

Hooshyar, Dariush

Arabi, Mohsen

KazemiJahromi, Mitra
Funding

Funding for this research was provided by:

Hormozgan University of Medical Sciences (990573)
License Information

Text and Data Mining valid from 2021-04-12

Version of Record valid from 2021-04-12
More Information

Article History

Received: 29 March 2021

Accepted: 31 March 2021

First Online: 12 April 2021

Declarations

:

: The protocol was approved by the ethics committee of Hormozgan University of Medical Sciences on February 14, 2021, with the code IR.HUMS.REC.1399.539. (ExternalRef removed)The authors confirm that this trial has received ethical approval from the appropriate ethical committee as described above. Written prospective informed consent will be obtained from participants before involvement in the trial in the Persian language.

: Written informed consent will be obtained from all participants/subject's legally acceptable representatives before inclusion in the trial for collecting data, analysis, storage, and publishing it.

: The authors declare that they have no competing interests.

Document is current